LIMITED STAGE LUNG SMALL CELL CARCINOMA
Clinical trials for LIMITED STAGE LUNG SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LIMITED STAGE LUNG SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LIMITED STAGE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could an immunotherapy booster improve lung cancer treatment?
Disease control OngoingThis phase III trial studies whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with limited stage small cell lung cancer live longer. About 544 participants receive either chemoradiation alone or chemoradiation plus atezolizumab. The main …
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
New combo aims to outsmart Chemo-Resistant lung cancer
Disease control OngoingThis phase 2 trial tests whether adding berzosertib to standard chemotherapy (topotecan) helps people with relapsed small-cell lung cancer live longer without their cancer growing. About 104 participants will receive either the combo or topotecan alone. The goal is to see if berz…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Brain radiation may be skipped in lung cancer: new trial tests safer monitoring
Disease control OngoingThis study tests whether using MRI brain scans alone to watch for cancer spread is as good as combining MRI with preventive brain radiation in people with small cell lung cancer. The goal is to see if avoiding radiation can reduce side effects and help patients live longer. About…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New cocktail of drugs targets Tough-to-Treat lung cancer
Disease control OngoingThis early-phase trial tests a combination of three drugs—tazemetostat, topotecan, and pembrolizumab—in 18 adults with small cell lung cancer that has returned after initial treatment. The goal is to find the safest dose and see if the combination can shrink or stabilize the canc…
Matched conditions: LIMITED STAGE LUNG SMALL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC